KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations. (Q54506769)

30 May 2018

title

KLF6 and TP53 mutations are a rare event in prostate cancer: distinguishing between Taq polymerase artifacts and true mutations. (English)

1 reference

30 May 2018

1 reference

1

1 reference

30 May 2018

author name string

Silvia Hernández

2

1 reference

30 May 2018

Silvia de Muga

3

1 reference

30 May 2018

José A Lorente

4

1 reference

30 May 2018

Núria Juanpere

5

1 reference

30 May 2018

Raquel Esgueva

6

1 reference

30 May 2018

Sergi Serrano

7

1 reference

30 May 2018

Antoni Gelabert

8

1 reference

30 May 2018

Josep Lloreta

9

1 reference

30 May 2018

publication date

19 September 2008

1 reference

30 May 2018

published in

Modern Pathology

1 reference

30 May 2018

volume

21

1 reference

30 May 2018

page(s)

1470-1478

1 reference

30 May 2018

issue

12

1 reference

30 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.2008.145

exact match

0 references

cites work

Prevalent mutations in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Molecular markers for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Krüppel-like factors: three fingers in many pies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

KLF6, a candidate tumor suppressor gene mutated in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Genetic and epigenetic alterations of the KLF6 gene in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Genetic alterations of the KLF6 gene in colorectal cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Difference in the role of loss of heterozygosity at 10p15 (KLF6 locus) in colorectal carcinogenesis between sporadic and familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Involvement of Kruppel-like factor 6 (KLF6) mutation in the development of nonpolypoid colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Genetic alterations of the KLF6 gene in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

The Kr√ºppel-like transcription factor 6 gene in sporadic pituitary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Roles of KLF6 and KLF6-SV1 in ovarian cancer progression and intraperitoneal dissemination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Absence of KLF6 gene mutations in human astrocytic tumors and cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Deletion, mutation, and loss of expression of KLF6 in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Mutation screening and association study of the candidate prostate cancer susceptibility genes MSR1, PTEN, and KLF6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Gene-expression profiles predict survival of patients with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Kruppel-like factor 6 germ-line mutations are infrequent in Finnish hereditary prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Shaping genetic alterations in human cancer: the p53 mutation paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Reactivation of mutant p53: molecular mechanisms and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

The p53 mutation "gradient effect" and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Unique substitution of CHEK2 and TP53 mutations implicated in primary prostate tumors and cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Molecular characterization of human prostate carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

p53 oncogene mutations in three human prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

A high frequency of sequence alterations is due to formalin fixation of archival specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Manual versus laser micro-dissection in molecular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

21 January 2018

Assessing EGFR mutations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

A Germline DNA Polymorphism Enhances Alternative Splicing of theKLF6Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

Genome-wide single nucleotide polymorphism analysis of lung cancer risk detects the KLF6 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

A new role for the Krüppel-like transcription factor KLF6 as an inhibitor of c-Jun proto-oncoprotein function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

[Epidemiological situation of prostate cancer in Spain]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

7 January 2021

Genomics of prostate cancer: is there anything to "translate"?

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

7 January 2021

In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

7 January 2021

Absence of KLF6 gene mutation in 71 hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

7 January 2021

Methylation status of genes upregulated by demethylating agent 5-aza-2'-deoxycytidine in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

7 January 2021

Gene expression profiling predicts clinical outcome of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

7 January 2021

KLF6 IVS1 -27G>A Variant and the Risk of Prostate Cancer in Finland

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

7 January 2021

Widely used prostate carcinoma cell lines share common origins

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.145

7 January 2021

10.1038/MODPATHOL.2008.145

Identifiers

DOI

1 reference

30 May 2018

PubMed ID

19020536

1 reference

30 May 2018